158 related articles for article (PubMed ID: 38345417)
1. Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils.
Lavoie JC; Simard M; Kalkan H; Rakotoarivelo V; Huot S; Di Marzo V; Côté A; Pouliot M; Flamand N
J Leukoc Biol; 2024 May; 115(6):1183-1189. PubMed ID: 38345417
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
3. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
6. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
8. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
[TBL] [Abstract][Full Text] [Related]
11. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
Cells; 2020 May; 9(5):. PubMed ID: 32438662
[TBL] [Abstract][Full Text] [Related]
12. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
13. T cell-intrinsic prostaglandin E
Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
[TBL] [Abstract][Full Text] [Related]
14. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
[TBL] [Abstract][Full Text] [Related]
15. Metabolic regulation by prostaglandin E
Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the S1P
Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
[TBL] [Abstract][Full Text] [Related]
18. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E
Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
[TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]